Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome [11]

British Journal of Dermatology

Volumn 156, Issue 6, 2007, Pages 1379-1380

  Tsirigotis, P ^a   Pappa, V ^a   Papageorgiou, S ^a   Kapsimali, V ^b   Giannopoulou, V ^a   Kaitsa, I ^a   Girkas, K ^a   Papageorgiou, E ^a   Stavrianeas, N ^a   Economopoulos, T ^a   Dervenoulas, J ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; BEXAROTENE;

ADULT; AGED; BACTEREMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; HYPOTHYROIDISM; LETTER; MALE; MYCOSIS FUNGOIDES; NAUSEA; PRIORITY JOURNAL; PUVA; SEZARY SYNDROME;

EID: 34447109708     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07901.x     Document Type: Letter

References (7)

1. Edelson R, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987 316 : 297 303.
2. Russell-Jones R. Shedding light on photopheresis. Lancet 2001 357 : 820 1.
3. Budgin JB, Richardson SK, Newton SB et al. Biological effects of bexarotene in cutaneous T-cell lymphoma. Arch Dermatol 2005 141 : 315 21.
4. Duvic M, Hymes K, Heald P et al. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol 2001 19 : 2456 71.
5. Quaglino P, Fiero MT, Rossotto GL et al. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy. Br J Dermatol 2004 150 : 327 36.
6. Zic AJ. The treatment of cutaneous T-cell lymphoma with photopheresis. Dermatol Ther 2003 16 : 337 46.
7. Knobler R, Jantschitsch Ch, Nahavandi H et al. Photopheresis in the treatment of cutaneous T-cell lymphoma. Haematologica 2003 88 (Suppl. 5 45 50.